Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edo H J Savelkoul

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Inflammatory Bowel Diseases|November 1, 2022
Systematic Review and Meta-analysis: Loss of Response and Need for Dose Escalation of Infliximab and Adalimumab in Ulcerative ColitisEdo H J Savelkoul, Pepijn W A Thomas, Lauranne A A P Derikx, et al.
European Journal of Gastroenterology & Hepatology|September 4, 2023
Cumulative thiopurine dosing and keratinocyte skin cancer in inflammatory bowel disease: a case-control studyFenna M Jansen, Nathan den Broeder, Satish F K Lubeek, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 2, 2022
Complete Endoscopic Healing Is Associated With Lower Relapse Risk After Anti-TNF Withdrawal in Inflammatory Bowel DiseaseRemi Mahmoud, Edo H J Savelkoul, Wout Mares, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Inflammatory Bowel Diseases|November 1, 2022
Systematic Review and Meta-analysis: Loss of Response and Need for Dose Escalation of Infliximab and Adalimumab in Ulcerative ColitisEdo H J Savelkoul, Pepijn W A Thomas, Lauranne A A P Derikx, et al.
European Journal of Gastroenterology & Hepatology|September 4, 2023
Cumulative thiopurine dosing and keratinocyte skin cancer in inflammatory bowel disease: a case-control studyFenna M Jansen, Nathan den Broeder, Satish F K Lubeek, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 2, 2022
Complete Endoscopic Healing Is Associated With Lower Relapse Risk After Anti-TNF Withdrawal in Inflammatory Bowel DiseaseRemi Mahmoud, Edo H J Savelkoul, Wout Mares, et al.
Pageof 1